170 related articles for article (PubMed ID: 20034139)
21. Implement postexposure guidelines or get sued.
AIDS Alert; 1996 Oct; 11(10):111-3. PubMed ID: 11363850
[TBL] [Abstract][Full Text] [Related]
22. Treatment. CDC urges wide use of AIDS drugs.
AIDS Policy Law; 2005 Feb; 20(3):1, 4. PubMed ID: 15744878
[No Abstract] [Full Text] [Related]
23. Guidelines for post-exposure treatment not likely soon.
AIDS Policy Law; 1997 Aug; 12(15):4-5. PubMed ID: 11364600
[TBL] [Abstract][Full Text] [Related]
24. Revised CDC guidelines underscore mother's health. Centers for Disease Control and Prevention.
AIDS Alert; 1998 Apr; 13(4):39-42. PubMed ID: 11365140
[TBL] [Abstract][Full Text] [Related]
25. The place of prevention in HIV clinical care: a roundtable discussion.
O'Rourke M; Auerbach J; del Rio C; Dooley S; Friedland G; Ridzon R
AIDS Clin Care; 2002 Jun; 14(6):49-53, 58. PubMed ID: 12061143
[No Abstract] [Full Text] [Related]
26. CDC releases detailed guidelines for PEP use. Agency focuses on nonoccupational exposure.
AIDS Alert; 2005 Apr; 20(4):42-4. PubMed ID: 15841527
[TBL] [Abstract][Full Text] [Related]
27. Postexposure prophylaxis for HIV exposed health care workers.
Robbins WA
AAOHN J; 2000 Mar; 48(3):148-51. PubMed ID: 10846973
[No Abstract] [Full Text] [Related]
28. CDC seeking to cut U.S. HIV infections in half.
J Calif Dent Assoc; 2001 Apr; 29(4):269. PubMed ID: 11346996
[No Abstract] [Full Text] [Related]
29. FDA notifications. Reyataz is approved for HIV treatment.
AIDS Alert; 2003 Sep; 18(9):119-20. PubMed ID: 14686309
[TBL] [Abstract][Full Text] [Related]
30. NIH funds New Orleans project to explore adherence among substance users. National Institutes of Health.
Fac Notes (New Orleans La); 1998; 10(3):5. PubMed ID: 11365350
[TBL] [Abstract][Full Text] [Related]
31. CDC takes a large tiger by the tail: how to handle post-exposure treatment. Centers for Disease Control and Prevention.
AIDS Alert; 1997 Sep; 12(9):97-100. PubMed ID: 11364588
[TBL] [Abstract][Full Text] [Related]
32. CDC says AIDS cases increased in U.S. for first time since 1993.
AIDS Policy Law; 2003 Feb; 18(4):1, 4. PubMed ID: 12691006
[No Abstract] [Full Text] [Related]
33. Treating opportunistic infections among HIV-exposed and infected children: recommendations from CDC, the National Institutes of Health, and the Infectious Diseases Society of America.
Mofenson LM; Oleske J; Serchuck L; Van Dyke R; Wilfert C
Clin Infect Dis; 2005 Feb; 40 Suppl 1():S1-84. PubMed ID: 15655768
[TBL] [Abstract][Full Text] [Related]
34. FDA notifications. FDA grants approval for raltegravir.
AIDS Alert; 2009 Apr; 24(4):46-8. PubMed ID: 19382366
[No Abstract] [Full Text] [Related]
35. 4-year update. CDC rewrites treatment guidelines, pushes for more public awareness.
AIDS Policy Law; 2006 Aug; 21(16):1, 4. PubMed ID: 17230632
[No Abstract] [Full Text] [Related]
36. FDA notifications. Investigational drugs to be more readily available?
AIDS Alert; 2007 Feb; 22(2):18-9. PubMed ID: 17763546
[No Abstract] [Full Text] [Related]
37. Hospital security: 'stay current' on HIV exposure treatment guidelines.
Hosp Secur Saf Manage; 1997 Dec; 18(8):1-3. PubMed ID: 10176068
[No Abstract] [Full Text] [Related]
38. HIV drugs. Doctors more concerned than patients about drug resistance.
AIDS Policy Law; 2006 Aug; 21(15):2. PubMed ID: 16969927
[No Abstract] [Full Text] [Related]
39. CDC recommends new guidelines for HIV tracking. Centers for Disease Control and Prevention.
AIDS Alert; 1999 Feb; 14(2):17-8. PubMed ID: 11366172
[TBL] [Abstract][Full Text] [Related]
40. NIH starts STI study.
AIDS Patient Care STDS; 2000 Apr; 14(4):225. PubMed ID: 10806644
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
